Skip to product information
1 of 1

  • Gphc Registered
  • Join over 100k customers
  • Fixed prices and no subscriptions
  • Discreet next day delivery.
  • Free shipping on all orders over £50

Numark (Tertiary) Migraine Relief 50mg Tabs 2's

Numark (Tertiary) Migraine Relief 50mg Tabs 2's

  • 1. Ozempic®️-equivalent therapy now available for weight management
  • 2. Average weight loss of 17%, with 1 in 3 patients achieving over 20%
  • 3. May help reduce osteoarthritis-related pain
  • 4. Wegovy®️ is not expected to impact the effectiveness of oral contraceptives
  • 5. Supports cardiovascular risk reduction
  • 6. Over 22 million patients treated with semaglutide-based therapies since 2018

We’re proud to offer fast and discreet delivery for all our medicines & treatments.

Price Checker

Regular price £6.39
Sale price £6.39
Sale Sold out
  • Lowest price guarantee
  • Includes FREE private prescription
View full details

The 50mg strength of Numark Migraine Relief tablets serves as a suitable treatment option for both menstrual cycle-related migraines and other acute migraine episodes. These tablets contain 50mg of sumatriptan which works to reduce migraine symptoms including headache and nausea and vomiting and sensitivity to light and sound. 

Key Features The active component of each tablet consists of 50mg sumatriptan succinate which functions as a selective serotonin (5-HT₁) receptor agonist to address migraine root causes. The medication starts working to reduce migraine symptoms about 30 minutes after patients take it. The medication provides dual benefits by treating both headache pain and nausea and vomiting and light sensitivity. The medication provides relief for menstrual migraines that occur due to hormonal fluctuations. Each pack includes two tablets which serve as a backup for people who experience infrequent severe migraine attacks or need occasional relief.

Usage Instructions Adult patients (18–65 years old) should take one tablet when migraine symptoms first appear. A person can take their second tablet after two hours if their symptoms return. The maximum number of tablets that can be taken in a 24-hour period is two. Not Suitable For: Individuals under 18 or over 65 years of age. The medication should not be used by patients who have heart conditions or liver or kidney diseases or who are pregnant or breastfeeding.

Product Composition The active component of the medication contains 50mg sumatriptan which exists as sumatriptan succinate. Inactive Ingredients: Lactose monohydrate, croscarmellose sodium, microcrystalline cellulose, silica colloidal anhydrous, magnesium stearate, hypromellose (E464), titanium dioxide (E171), macrogol, glycerol triacetate, iron oxide red (E172), iron oxide yellow (E172), and iron oxide black (E172).

Patient Information Leaflet

Important - Before taking any medication, it is always important to read the Patient Information Leaflet (PIL)

Written and reviewed by our qualified team

GPhC Number: 2233073
Tarun Kumar

Reviewed by:

Tarun Kumar

Superintendent/ Clinical Lead

📖 Find out more about our team of medical content authors and how we ensure the accuracy of our content with our content guidelines.

Content last updated: 31 Mar 2025

We’re a safe and
regulated UK service

Registered Pharmacy Badge

Lowest Price Guarantee

We're convinced you won't find your treatment cheaper, but if you do we'll refund the difference.

Find out more

100% discreet packaging

We're convinced you won't find your treatment cheaper, but if you do we'll refund the difference.

Find out more

Agent

Need help?
Talk to our friendly experts now

How our service works

Service Setup

Service setup

Discreet Packaging

Discreet packaging

Express Delivery

Express delivery

Comparison of Weight Loss Injectables

Features

Mounjaro®

Injectable Pen

Wegovy®

Injectable Pen

Saxenda®

Injectable Pen

Active Ingredient Tirzepatide Semaglutide Liraglutide
Mechanism of Action GLP-1 and GIP receptor agonist GLP-1 receptor agonist GLP-1 receptor agonist
Administration Weekly injection Weekly injection Daily injection
Dosage Varies by patient, typically starting low Varies, typically starting at 0.25 mg Varies, starting at 0.6 mg
Effect on Appetite Significantly reduces appetite and cravings Reduces appetite and increases satiety Reduces appetite and increases satiety
Average Weight Loss Up to 20% body weight reduction Up to 15% body weight reduction Significant weight reduction
Side Effects Nausea, vomiting, diarrhoea, constipation Nausea, vomiting, diarrhoea, constipation Nausea, diarrhoea, constipation, hypoglycemia
Approval FDA-approved for weight loss FDA-approved for weight loss FDA-approved for weight loss
Suitable For Adults with BMI ≥30 or ≥27 with comorbidities Adults with BMI ≥30 or ≥27 with comorbidities Adults with BMI ≥30 or ≥27 with comorbidities